Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

retroviral * ritonavir 165

-Keyword

Abstract

ective pseudotyping of vectors with SIVagm Env and sel 41245
etween monomers in envelope oligomer during memb 60445
) Department of Health Retrovirology Laboratory from 1993-199 42116
he human endogenous retrovirus HERV-K/A Rev/RRE-like mech 11208
ommunity based group: REVS +/Experience of a widow (PWA) and 34305
g with HIV: The case of + in Burkina Faso/Socio-cultural obs 60234
on hospital/Comparing RFLP IS6110 and PGRS fingerprinting in t 13203
ducation project among RFSW and MSM/AIDS surveillance and e 23558
ve routes, boosted with rgp 120/A Phase I trial of vaccinia-env/gag 496*/21199
mokine receptor on HIV 120-induced B lymphocyte function/Ro 31159
AIDS and CMV retinitis/ Rhegmatogenous retinal detachment ass 32237
HBV surface antigen in rhesus macaques: Role of HIV specific cyt 11240
ions/AIDS induction in monkeys with a mutant SHIV by sy 11244
f children to participate: Rhetoric or reality?/HIV and the rights of c 34348
uman growth hormone ( rhGH) in HIV-infected (HIV+) men who los 60389
ecting drug users in the Rhode Island Needle Exchange Program/ 23236
oral risk factor survey in Island/Factors associated with prio 43145
SEDA and GAEI study/ Rhodococcus equi infection in AIDS patie 22111
a study of lenograstim ( rHuG-CSF ) to allow optimal ganciclovir tre 32146
ious Diseases "Emilio Ribas " (IIER), S&o Paulo, SP, Brazil/AIDS 60580
f a University Hospital, Ribeirdo Preto, Sao Paulo, Brazil/Detecti 13394
g health care workers in Preto, Sao Paulo, Brazil/Surveill 23337
ion of lymphoma using ribonucleotide reductase inhibitors (RRIs 12356
packageable multimeric ribozymes /Anti-HIV-1 gene therapy using 41247
no Delle Associazioni - Ricerca su Terapie complementari in HIV/ 42378
enz (EFV) and rifampin ( RIF ) in healthy volunteers/Pharmacokineti 42280
cebo-controlled trial of rifabutin added to a regimen of clarithromy 22176
/Comparative study of absorption and disposition in HIV 32171
dividuals: Isoniazid vs. /Multinational study for the preve 60858
0)/A randomized trial of rifampin /pyrazinamide for 2 months vs. IN 447*/22126
en efavirenz (EFV) and (RIF) in healthy volunteers/Phar 42280
n nevirapine (NVP) and (RMP)/Pharmacokinetic (PK) int 60623
-reservoir cells/Human rlL-16 exerts potent HIV-suppressing activ 21185
IV-infected individuals/ rlL-2 rescues in vitro functions of lymphocy 31185
perience with proleukin ( rlL 2) in HIV-infected patients/Experience 22413
g in a support house in Rio de Janeiro, Brazil/Analysis of vitamin 12121
an inner city hospital in /Prevalence of HIV among 13163
t a university hospital in, Brazil/Decline in AIDS-rel 13176
DS patients in the City of /Tuberculosis diagnosis in 13262
berculosis in the City of /HIV seropositivity among 13272
men from slum areas in, Brazil/Evaluating a traini 13425
use at urban schools in /Training of health agents 13526
g university students in /Sexual transmission of HI 13545
n of HIV transmission in city, Brazil/Evaluation of a 13579
dy on HIV incidence in, Brazil/Sexual behaviour 14106
s of medical students in,Brazil/Assessing the heal 14130
V infected women from, Brazil/Social-behaviour p 14355
HIV-infected patients in, Brazil/Risk factors for tub 22132
n adult AIDS patients in, Brazil/Clinical aspects of 22142
ents with tuberculosis in, Brazil/HIV screening in p 22149
pital, AIDS reference in, Brazil/Drug-resistant Myc 22163
hips by bisexual men in,Brazil/Condom usage by 23107
rea and inner cities in State, Brazil/AIDS & educ 23127
injecting drug users, in, Brazil/Higher frequency o 23212
HTLV-I/II among IDUs in, Brazil/Prevalence of HIV- 23248
vertical transmission in, Brazil/Main difficulties in t 23311
g health care workers in City, Brazil/Profile of occu 23332
f the prison system of /Health evaluation of the in 23537
STDs in gate prisons of (1996/1997)/Comparison 23562
tion in prison system of, Brazil- 1997/Prevalence 23563
y in the prison system of, Brazil/Risk behaviour, pe 23568
S preventive behavior in, Brazil/Impact of religious 23587
tion in prison system of, Brazil/STDs, HIV/AIDS a 23592
IDS voluntary sector in, Brazil/Identities and soci 24102
Universitary Hospital in /Psychosocial characterist 24372
cupational exposure in City/Implementation of a s 33187
ne preparatory study in, Brazil/Willingness to parti 33337
omplex environment of City/Implementing a harm 411*/33390
r injecting drug users in, Brazil/The relevance of th 33399
among cocaine users in, Brazil/Reducing HIV risk 33407
ns in the municipality of, Brazil, during 1997/The u 42300
omission on AIDS of, Brazil/Partnership betwe 43201
cue and construction in BR poor communities - A 43214
am for social workers in /Training program for soci 43363
on the prison system of /STD/AIDS prevention thr 43407

or the prison system of /Specific information mate 43416
ss of AIDS reporting in:A linkage study between s 43448
HIV infection incidence, State, Brazil, 1995-2000/ 43495
s among adolescents in State, Brazil/AIDS epide 60284
AIDS mortality impact in State, Brazil/AIDS mortali 60430

SKeyword Abstr
antiretroviral therapy in, Brazil/Follow-up of homel
es in a poor community,, Brazil/DST/AIDS: Epide
ention OS STD/AIDS -, Brazil/Teenagers living in
IV infected prisoners of, Brazil/Study on sexuality,
me pregnant women in - Brazil/High prevalence o
V+ pregnant women in, Brazil/Antiretroviral thera
vertical transmission in, Brazil/Feasibility of AZT u
HIV-infected women in, Brazil/STD and other gyn
ommunity education in Risaralda, Colombia/Learning from AIDS:
rs: Identification of HIV risk-behavior patterns and implications to
Race, age, gender, and risk-group difference in rates of suspicion
Barriers to adopting HIV risk-reduction behaviours in Malawian yo
y men from an existing program/Creating a cultur
al functionality to inform programs for crack users/
Effects on reducing HIV risk-related behavior/Recruiting out-of-tre
tionships report sexual risk-taking with primary and non-primary
nowledge, attitude and behaviours towards HIV/AIDS
gnancy and HIV sexual among female adolescents/T
s: Predicting the sexual of gay and bisexual men/Conn
duce or increase sexual?/Gay identification: Does it re
s: Predicting the sexual of gay and bisexual men/Conn
of Cameroon/Practices risking the infection of HIV/AIDS in the gra
ssion of HIV in Uganda/ Risks for heterosexual transmission of HIV
rogram in reducing sex risks among urban youth/The effectivene
ewives/Implications on of HIV infection - genital tract infectio
evaluate the community of HIV epidemic using sentinel behav
erceived sexual health for a culturally diverse group of South
en/Understanding HIV of drug-using men who have sex with
m/HIV/STD status and for frequent visits to female sex work
rug users report higher for HIV and drug-related harm in San
IV serostatus and STD in the collaborative injection drug use
GC) and the associated of HIV infection?/Could the REACH
Brazil/Increasing the for the female partner: Perception an
tections and imaginary the case of the french homosexual mi
e prophylaxis for sexual: Implications for behavioral preventio
Drug treatment and HIV: It's not just about needles anymore/
women in reducing the of contracting AIDS/Programmes th
Which women will take? Predictors of lack of contraceptive u
roprevalence/Relative of injection drug use and crack smoki
a/Perceived and actual of occupational HIV transmission am
Ritonavir + saquinavir ( RIT + SAQ) salvage therapy in antiretrovira
nz (EFV) and ritonavir ( ) after multiple oral doses in healthy vol
ased on in vitro model/ Ritonavir-containing dual protease inhibi
pdate/Phase II study of ritonavir-nelfinavir combination therapy:
d HIV-infected patients/ Ritonavir-Saquinavir (RTV/SQV) combin
linical trial comparing a ritonavir-saquinavir versus an indinavir c
patients after 72 weeks/ Ritonavir (RTV)-saquinavir (SQV) in prote
-experienced patients/ + saquinavir (RIT + SAQ) salvag
py after indinavir failure/ + saquinavir as a rescue therapy
r ritonavir resistance/, saquinavir, and nevirapine as a
ealthy volunteers (HV)/ (RTV) low dosages increases dr
n HIV-infected children/ promotes increased growth in HI
unty Hospital, Chicago/ + saquinavir + 2 NRTIs as first lin
cy of reduced doses of ritonavir (RTV) plus saquinavir (SQV) in th
atients/Experience with in HIV+ pediatric patients/Experi
ve patients/Saquinavir/ may have better antiviral efficacy
mised study comparing and indinavir in 1251 previously tr
icacy and tolerability of in HIV-infected children/First larg
en/Short-term effects of and nelfinavir in HIV-infected chil
nfection/Response to in severely immunocompromised
oviral therapy including in children with HIV-1/Combinati
patients starting either (R), Indinavir or saquinavir (S) in
ry results/Treatment of (RTV)/saquinavir (SQV) versus
erability and efficacy of /Effect of dose escalation on the s
tiretroviral therapy with in pediatric HIV infection/Combin
of two dose regimens of and saquinavir used as rescue th
apy with saquinavir and plus stavudine/Virologic long-ter
istic anti-HIV activity of and other protease inhibitors in th
icacy and drug levels of /saquinavir combination salvage t
riple therapy: Indinavir, or saquinavir combined with 3TC
ociated with successful salvage therapy in an open trial of
fficacy and durability of /saquinavir (RTV/SQV) as salvag
stitution for indinavir or /saquinavir in HIV+ suppressed b

of children treated with in combination therapy for HIV inf
ty of the combination of plus saquinavir, with two nucleosi
y or in combination with in patients with chronic liver disea
inary results/Impact of /saquinavir versus ritonavir/saqui
udine, lamivudine and (ZLR)/Correlations between imm
regimen for indinavir or resistance/Ritonavir, saquinavir,
when administered with /Indinavir can be taken with regul

act
60528
60563
60829
60903
60913
61001
61002
61004
14228
23227
42215
14195
33553
43241
33398
14176
14194
34226
42396
60503
60553
60953
23382
13532
13577
14127
14238
23129
23158
23202
23235
23384
23448
24112
33184
60476
60710
60788
60850
60873
12310
42269
22350
12207
22390
12265
12295
12310
12324
22356
42257
60361
60619
12114
12173
126*/12221
132*/12237
173*/12246
12251
12254
12259
12273
291*/12274
12283
12296
12307
12313
12315
12316
12317
12318
12330
12332

12333
12336
12378
14338
21129
22356
22361